Join the club for FREE to access the whole archive and other member benefits.


Leading regenerative medicine company and developer of advanced cell-based therapeutics

Ixaka (formerly Rexgenero) is a private UK-based cell and gene therapy company with operations in the UK, Spain and France. The company is focused on the natural power of the body to cure disease. Our proprietary technologies enhance the inherent therapeutic power of cells by targeting curative cells to the site of disease and by directly modifying cells within the body to improve their therapeutic action. Ixaka’s technologies – concentrated multi-cell therapies and targeted nano-particles – demonstrate potential for the treatment of a broad range of serious diseases across oncology, cardiovascular, neurological and ocular diseases, and genetic disorders.

Visit website:



Details last updated 03-Oct-2019

Topics mentioned on this page:
Regenerative Medicine, Stem Cells